about
Overview of the biology of type I interferonsTNF biology, pathogenic mechanisms and emerging therapeutic strategiesProliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesIndirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins.Modulation of TNF-induced macrophage polarization by synovial fibroblasts.Targeting cytokines in inflammatory diseases: focus on interleukin-1-mediated autoinflammationSuppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin.Kinase inhibitors: a new tool for the treatment of rheumatoid arthritis.Blood-induced arthropathy in hemophilia: mechanisms and heterogeneity.Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes.Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment.Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.A new tool for detection of type I interferon activation in systemic lupus erythematosus.Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.Of temples and plane trees: the Hippocratic legacy as collective memory.Hippocrates and genomic medicine.Pharmacogenetic principles in the Hippocratic writings.Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis.Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy.Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.Synovial fibroblasts display an uncontrolled inflammatory and tissue destructive response to TNF-αType I interferons as biomarkers in autoimmune diseasesTNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysisThe future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
P50
Q21195364-AA90F098-883A-4C1C-A039-60C632535C38Q26776492-69ED10F9-E32B-4444-85F0-B8925FB52AD0Q33733803-A51C327B-D5AB-4B85-9E80-8C3D07A7622AQ33822008-F91ABEF6-E86E-4A04-9BB8-6BF38854EE13Q34053962-24D9C063-7B0B-4F43-B00B-8BE5A729D200Q34167205-1AE71D85-434D-403A-AA15-6CE8A735DDC1Q34482169-2AA06B14-C583-4130-A24C-AE292B50D739Q35684207-00E55EFE-3164-4530-80E3-514D12AD4951Q38104862-510F9915-662C-466D-8130-020E820C1E1BQ38603031-612FD21C-9104-4167-ADD9-11D5F701CA95Q39648944-0A0CDE7B-79DA-4383-9D99-406A9B225190Q40876695-2776C8D5-0990-4106-ACCF-0C3A94C08DA6Q41017195-2AD0D65E-6B7B-4028-A01B-B2CC623C07C3Q42255597-4C13087F-FD9E-4771-AB07-00151F795ED9Q42326768-A9E374C9-049F-4AB8-84E2-F559EE2B113BQ42410300-DBA01D64-AC2C-4811-9B0A-452699FB092DQ42420312-8FF179B4-28C1-4613-9FFC-13C1A2FD85C3Q42426990-A31E7513-AAF4-42CE-810B-0EDA6F335008Q47215051-C73AB460-6721-48B4-AC68-F9B0000388A7Q47237476-93200BC6-44C5-422A-924C-1FB44456F949Q47244044-90913A72-6843-47CF-8E48-3B5BAA38AD27Q51767593-975A0CCC-BB39-4AA2-A7FF-BCC199FA3EA3Q51887350-A20B8791-B94C-4D4F-B983-CF43E33136EDQ53517990-BE0D0FCD-8DBD-481A-AEED-B0D7B7F017AAQ59616308-5BB21CF6-F687-4B5A-BB48-D6EC355B1F83Q83744562-64BA85F8-0B3D-4A88-B0F9-89603CF036D8Q92088448-A602C01C-E69B-46D0-9724-47B8B5EBCB54Q94691751-B6DB9314-9915-40A6-9A8D-169DB7F81474
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
George D. Kalliolias
@ast
George D. Kalliolias
@en
George D. Kalliolias
@es
George D. Kalliolias
@nl
George D. Kalliolias
@sl
type
label
George D. Kalliolias
@ast
George D. Kalliolias
@en
George D. Kalliolias
@es
George D. Kalliolias
@nl
George D. Kalliolias
@sl
prefLabel
George D. Kalliolias
@ast
George D. Kalliolias
@en
George D. Kalliolias
@es
George D. Kalliolias
@nl
George D. Kalliolias
@sl
P106
P1153
15769439800
P21
P31
P496
0000-0002-4427-8245